Guru Ownership Trend
Guru Analysis for Kalaris Therapeutics, Inc. (KLRS)
Kalaris Therapeutics, Inc. (KLRS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $622,793.67.
Top institutional holders include Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $338,624.24 net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 125.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Kalaris Therapeutics, Inc. (KLRS)
Major holders include Renaissance Technologies (RenTech) ($607,859). According to the latest reported data, 1 tracked investment managers collectively hold approximately 149,351 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $338,624.24, with 1 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in KLRS during the most recent reporting period.
Yes, 0 managers opened new positions in KLRS, and 1 increased their existing holdings. The total reported buy value was $338,624.24.